Lineage Cell Therapeutics, Inc.: capex

Value{"amount": 399000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"}
Period2018-01-01 – 2018-09-30
Statuscurrent
EntityLineage Cell Therapeutics, Inc.
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference: 0001493152-18-015428 · Open the official SEC filing →
Retrieved: 2026-08-19T08:43:16.416080+02:00
Raw response sha256: f7bde1a401b286c74a2fd824ee1df541…
Also addressable by official identifiers: https://factanker.com/fact/sec/cik-0000876343/capex/2018-09-30 (CIK, metric, reporting date)
Cite as: FACTANKER, https://factanker.com/fact/45702e45-1588-4e71-8dc4-e30ff38e3e5b

History

From the Record
32 US software companies haven’t lost money in a decade. One of them is steadier than all the rest.
Read the findingSearch 53 million companies